Showing results (131-140 of 281) with videos related to
Sort By:
Pageof 29
JACC. Cardiovascular Interventions|September 7, 2024
5-Year Outcomes of Anterior Mitral Leaflet Laceration to Prevent Outflow ObstructionJaffar M Khan, Vasilis C Babaliaros, Adam B Greenbaum, et al.Circulation. Cardiovascular Interventions|May 18, 2021
BASILICA Trial: One-Year Outcomes of Transcatheter Electrosurgical Leaflet Laceration to Prevent TAVR Coronary ObstructionJaffar M Khan, Adam B Greenbaum, Vasilis C Babaliaros, et al.Journal of the American Heart Association|August 16, 2021
Additive Value of Preprocedural Computed Tomography Planning Versus Stand-Alone Transesophageal Echocardiogram Guidance to Left Atrial Appendage Occlusion: Comparison of Real-World PracticeChak-Yu So, Guson Kang, Pedro A Villablanca, et al.Circulation. Cardiovascular Interventions|December 17, 2017
ACIST-FFR Study (Assessment of Catheter-Based Interrogation and Standard Techniques for Fractional Flow Reserve Measurement)William F Fearon, Jeffrey W Chambers, Arnold H Seto, et al.Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|September 24, 2017
Safety and efficacy of the next generation Resolute Onyx zotarolimus-eluting stent: Primary outcome of the RESOLUTE ONYX core trialMatthew J Price, Richard A Shlofmitz, Douglas J Spriggs, et al.Journal of the American College of Cardiology|February 21, 2006
Serial angiographic follow-up of sirolimus-eluting stents for unprotected left main coronary artery revascularizationMatthew J Price, Ecaterina Cristea, Neil Sawhney, et al.Circulation|August 31, 2011
Platelet reactivity and cardiovascular outcomes after percutaneous coronary intervention: a time-dependent analysis of the Gauging Responsiveness with a VerifyNow P2Y12 assay: Impact on Thrombosis and Safety (GRAVITAS) trialMatthew J Price, Dominick J Angiolillo, Paul S Teirstein, et al.JACC. Cardiovascular Interventions|July 22, 2017
First Report of the Resolute Onyx 2.0-mm Zotarolimus-Eluting Stent for the Treatment of Coronary Lesions With Very Small Reference Vessel DiameterMatthew J Price, Shigeru Saito, Richard A Shlofmitz, et al.Journal of the American College of Cardiology|May 26, 2012
Influence of genetic polymorphisms on the effect of high- and standard-dose clopidogrel after percutaneous coronary intervention: the GIFT (Genotype Information and Functional Testing) studyMatthew J Price, Sarah S Murray, Dominick J Angiolillo, et al.Journal of the American College of Cardiology|June 16, 2012
Recovery of platelet function after discontinuation of prasugrel or clopidogrel maintenance dosing in aspirin-treated patients with stable coronary disease: the recovery trialMatthew J Price, James S Walder, Brian A Baker, et al.Pageof 29